Daniel Rea

Publications

  1. 2021
  2. Published

    Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

    Aug 2021, In: The Lancet Oncology. 22, 8, p. 1139-1150 12 p.

    Research output: Contribution to journalArticlepeer-review

  3. E-pub ahead of print

    Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study

    Daniel Rea, Dec 2021, In: Breast Cancer. 7, 1, 13 p., 90.

    Research output: Contribution to journalArticlepeer-review

  4. E-pub ahead of print

    Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial

    & 2 others, Daniel Rea & , Dec 2021, In: Breast Cancer. 7, 1, 8 p., 74.

    Research output: Contribution to journalArticlepeer-review

  5. E-pub ahead of print
  6. Published

    The effect of metformin vs placebo on sex hormones in Canadian cancer trials group MA.32

    Daniel Rea & 5 others, , , , & , Feb 2021, In: Journal of the National Cancer Institute. 113, 2, p. 192-198 7 p.

    Research output: Contribution to journalArticlepeer-review

  7. 2020
  8. Published

    Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial

    Daniel Rea & 8 others, , , , , , , & , Oct 2020, In: The Lancet Oncology. 21, 10, p. 1296-1308 13 p.

    Research output: Contribution to journalArticlepeer-review

  9. Published

    Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training

    3 Sep 2020, In: PLoS ONE. 15, 9 September, e0238593.

    Research output: Contribution to journalArticlepeer-review

  10. Published
  11. E-pub ahead of print

    Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK

    Daniel Rea, , , , , , , , , , , , & , 25 Jul 2020, (E-pub ahead of print) In: Clinical Oncology.

    Research output: Contribution to journalArticlepeer-review

  12. E-pub ahead of print

    Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials

    Daniel Rea, , , , , , , , & , 24 Jul 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . p. JCO1902427

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 4 5 6 7 8 ...13 Next